ResMed ready to capitalise on ‘foot fault’ by rival Philips
MELBOURNE: ResMed boss Mick Farrell says the company can secure long-term market share gains after
MELBOURNE: ResMed boss Mick Farrell says the company can secure long-term market share gains after